Q2 2021 Holdings
Filed 2021-08-13 | 9 holdings | $240.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bioventus(BVS) | COM CL A | 09075A108 | $212.9M | 12,096,702 | 88.4% |
| Axogen Inc(AXGN) | COM | 05463X106 | $27.6M | 1,276,645 | 11.5% |
| Mimedx Group, Inc.(MDXG) | COM | 602496101 | $292.4K | 23,376,623 | 0.1% |
| Venus Concept, Inc. | COM | 92332W105 | $38.6K | 12,417,856 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $37.7K | 4,190,921 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $37.3K | 1,333,692 | 0.0% |
| Tela BIO, Inc.(TELA) | COM | 872381108 | $25.5K | 1,580,089 | 0.0% |
| Medicinova Inc(MNOV) | COM NEW | 58468P206 | $4.7K | 1,105,941 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $340 | 78,622 | 0.0% |